Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
Gervais
Francois G
FG
Department of Respiratory and Inflammation, Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA. francois_gervais@merck.com
Sawyer
Nicole
N
Stocco
Rino
R
Hamel
Martine
M
Krawczyk
Connie
C
Sillaots
Susan
S
Denis
Danielle
D
Wong
Elizabeth
E
Wang
Zhaoyin
Z
Gallant
Michel
M
Abraham
William M
WM
Slipetz
Deborah
D
Crackower
Michael A
MA
O'Neill
Gary P
GP